Bicara Therapeutics Vs. Old Point Financial Industry Stock Comparison

Sell

8

BCAX
Bicara Therapeutics

Last Price:

$10.56

Seasonality Move:

--

Buy

81

OPOF
Old Point Financial

Last Price:

$36.54

Seasonality Move:

-2.67%

Sell

8

Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

The current Bicara Therapeutics [BCAX] share price is $10.15. The Score for BCAX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
BCAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

81

Old Point Financial (OPOF) is a Buy

Is Old Point Financial a Buy, Sell or Hold?

The current Old Point Financial [OPOF] share price is $37.07. The Score for OPOF is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
OPOF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

The Bicara Therapeutics share price today is $10.15

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight selling pressure.

OPOF Stock Price Chart

What is Old Point Financial's stock price today?

The Old Point Financial share price today is $37.07

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OPOF is experiencing slight buying pressure.

BCAX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.87	Sell
Relative Strength Index (14 RSI):	37.28	Sell
Chaikin Money Flow:	-120620	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.03 - 14.39)	Sell
Bollinger Bands (100):	(11.78 - 18.38)	Sell

OPOF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.05	Buy
Relative Strength Index (14 RSI):	80.47	Buy
Chaikin Money Flow:	4187	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(28.8 - 34.5)	Buy
Bollinger Bands (100):	(22.67 - 30.65)	Buy

BCAX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.97	Sell
20-day SMA:	12.23	Sell
50-day SMA:	12.79	Sell
200-day SMA:	0	Buy
8-day EMA:	10.82	Sell
20-day EMA:	11.89	Sell
50-day EMA:	12.95	Sell
200-day EMA:	11.31	Sell

OPOF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35	Buy
20-day SMA:	31.99	Buy
50-day SMA:	29.57	Buy
200-day SMA:	22.31	Buy
8-day EMA:	35.3	Buy
20-day EMA:	32.93	Buy
50-day EMA:	30.17	Buy
200-day EMA:	24.04	Buy

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.

Old Point Financial Earnings Growth & OPOF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bicara Therapeutics Technical Analysis

	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7	Apr 8	Apr 9	Apr 10
	Mar			Apr
	28	31	01	02	03	04	07	08	09	10
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Old Point Financial Technical Analysis

	Mar 28	Mar 31	Apr 1	Apr 2	Apr 3	Apr 4	Apr 7	Apr 8	Apr 9	Apr 10
	Mar			Apr
	28	31	01	02	03	04	07	08	09	10
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):